PNC Financial Services Group’s IGM Biosciences IGMS Stock Holding History

PNC Financial Services Group’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5	Closed	-$6	–	5146
2025 Q2	$6	Sell	5 -849	-99%	-$1.04K	﹤0.01%	4901
2025 Q1	$982	Buy	854 +831	+3,613%	+$1.54K	﹤0.01%	4521
2024 Q4	$141	Hold	23	–	–	﹤0.01%	4688
2024 Q3	$380	Hold	23	–	–	﹤0.01%	4601
2024 Q2	$158	Buy	23 +16	+229%	+$137	﹤0.01%	4691
2024 Q1	$68	Hold	7	–	–	﹤0.01%	4656
2023 Q4	$58	Buy	+7	New	+$41	﹤0.01%	4548
2021 Q3	–	Sell	-12	Closed	-$1K	–	4347
2021 Q2	$1K	Buy	+12	New	+$889	﹤0.01%	4118

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

PNC Financial Services Group's IGMS Position: Q3 2025 in Review

PNC Financial Services Group sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 5 shares — an estimated $6 sold.

PNC Financial Services Group first reported a position in IGMS in Q2 2021 and held it in 8 quarters. The position peaked at $1K in Q2 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

PNC Financial Services Group reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
PNC Financial Services Group sold 5 IGM Biosciences shares in Q3 2025, an estimated $6.
PNC Financial Services Group first reported a position in IGM Biosciences in Q2 2021 and held it in 8 quarters.
PNC Financial Services Group's IGM Biosciences position peaked at $1K in Q2 2021.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.